Back
Speaker illustration

Doctor Mi Joo Kim

Daejeon (Korea (Republic of))

Presentations

Comparison of the new oral P2Y12 inhibitor (Prasugrel/Ticagrelor) to Clopidogrel in type 2 diabetes mellitus patients with AMI

Event: ESC Congress 2016

Topic: Thrombosis and platelets

Session: Antiplatelet therapy

Access
Like
Thumbnail

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources